Work

The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy.

Year: 2016

Type: article

Study design: Observational Study

Source: PubMed

Authors: Martin Svaton, Ondrej Fiala, Milos Pesek, Zbynek Bortlicek, Marek Minarik, Lucie Benesova, Ondrej Topolcan

Institutions: Charles University, Masaryk University, Genomac

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2299214622

FWCI: 2.244

Cites:

Cited by: 37

Related to: 10